IL160242A0 - Methods for the treatment and prognosis of leukemia and other cancer types - Google Patents

Methods for the treatment and prognosis of leukemia and other cancer types

Info

Publication number
IL160242A0
IL160242A0 IL16024202A IL16024202A IL160242A0 IL 160242 A0 IL160242 A0 IL 160242A0 IL 16024202 A IL16024202 A IL 16024202A IL 16024202 A IL16024202 A IL 16024202A IL 160242 A0 IL160242 A0 IL 160242A0
Authority
IL
Israel
Prior art keywords
prognosis
leukemia
treatment
methods
cancer types
Prior art date
Application number
IL16024202A
Original Assignee
Fund For Medical Res Dev Of In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund For Medical Res Dev Of In filed Critical Fund For Medical Res Dev Of In
Publication of IL160242A0 publication Critical patent/IL160242A0/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57426Specifically defined cancers leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16024202A 2001-08-07 2002-08-07 Methods for the treatment and prognosis of leukemia and other cancer types IL160242A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31025601P 2001-08-07 2001-08-07
PCT/IL2002/000649 WO2003013422A2 (en) 2001-08-07 2002-08-07 Methods for the treatment and prognosis of leukemia and other cancer types

Publications (1)

Publication Number Publication Date
IL160242A0 true IL160242A0 (en) 2004-07-25

Family

ID=23201665

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16024202A IL160242A0 (en) 2001-08-07 2002-08-07 Methods for the treatment and prognosis of leukemia and other cancer types

Country Status (4)

Country Link
EP (1) EP1451218A4 (en)
CA (1) CA2456909A1 (en)
IL (1) IL160242A0 (en)
WO (1) WO2003013422A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1704414A4 (en) * 2004-01-07 2008-04-16 Rambam Medical Ct Funds For Me Induction of apoptosis via arts-iap complexes
US20150018285A1 (en) 2012-02-15 2015-01-15 Carmel-Haifa University Economic Corporation Ltd. ANTAGONISTS OF Bcl-2 AND USES THEREOF IN INDUCTION OF APOPTOSIS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3141107B2 (en) * 1998-11-16 2001-03-05 工業技術院長 Human-derived bradion protein, DNA encoding the same, and uses thereof
AU2001231141A1 (en) * 2000-01-29 2001-08-07 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Novel human septin and uses thereof

Also Published As

Publication number Publication date
CA2456909A1 (en) 2003-02-20
EP1451218A4 (en) 2006-03-08
WO2003013422A2 (en) 2003-02-20
WO2003013422A3 (en) 2004-05-21
EP1451218A2 (en) 2004-09-01

Similar Documents

Publication Publication Date Title
IL251270A0 (en) Cancer treatment
EG24356A (en) Antitumor compounds and methods
AU6147401A (en) Compositions and methods for the treatment of cancer
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
AU2002331290A1 (en) Methods for the treatment of cancer with irinotecan based on cyp3a5
AU2002348135A1 (en) Methods for the treatment of addiction
EP1442062A4 (en) Methods for the treatment of carcinoma
MXPA03008582A (en) Agents and methods for treatment of cancer.
EP1509539A4 (en) Novel compositions and methods for cancer
GB2389532C (en) The method of treating cancer
PL368035A1 (en) Compositions and methods for the treatment of cancer
EP1469769A4 (en) Novel compositions and methods for cancer
MXPA03007036A (en) Method of cancer therapy.
EP1401377A4 (en) Methods for treating cancer
AU2003223538A1 (en) Methods for the treatment of cancer
EP1469870A4 (en) Novel compositions and methods for cancer
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2002327643A1 (en) Detection and treatment of cancers of the liver
IL160242A0 (en) Methods for the treatment and prognosis of leukemia and other cancer types
AU2002304883A1 (en) Device for the treatment of tumours
AU2004281077A1 (en) Methods and agents for the treatment of cancer
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2002360454A8 (en) Methods and compositions for treating cancer
WO2003020115A9 (en) Methods and compositions for the detection of cancer
AU2001237414A1 (en) Cancer treatment and prognosis